110 results
Page 2 of 6
8-K
chkdqbdo
25 Jul 22
Departure of Directors or Certain Officers
4:48pm
8-K
EX-10.1
9b0rtar7c7otlyqht7se
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
q4e0uevca5sbrynk4vth
24 Mar 22
Prospectus supplement for primary offering
4:15pm
424B5
hldemzxdxurd524y
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
clin9
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
wphxsxq4ib
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
424B3
2t6n gahx
12 Apr 21
Prospectus supplement
1:44pm